Literature DB >> 25877008

Quantification of the APE2 gene expression level in Candida albicans clinical isolates from patients with diagnosed fungal infections.

M Staniszewska1, M Bondaryk, K Żukowski, M Chudy.   

Abstract

The production of hydrolytic enzymes is considered a key virulence determinant of Candida albicans. Aminopeptidase 2 (Ape2) facilitates the penetration of C. albicans into the host tissue, by providing free amino acids to support fungal growth and proliferation. The objective of this study was to estimate the APE2 expression profile in C. albicans cells during invasion of the human epithelium. Sixty-one clinical fungal isolates and five reference strains were included in this study. The wild-type APE2 sequence was analyzed by polymerase chain reaction (PCR) amplification using genomic DNA from pathogenic isolates. Amplicons were verified in 1% agarose gel and visualized by illumination with ultraviolet (UV) light. The APE2 expression levels were analyzed with reverse transcription quantitative real-time PCR (RT-qPCR) and APE2 quantification was normalized against the reference gene in C. albicans cells grown in YEPD and during Caco-2 invasion. The APE2-specific PCR product band was found in all C. albicans and C. dubliniensis strains, but not in other common pathogenic fungi. APE2 transcript abundance was elevated in the clinical isolates growing on the Caco-2 cell line in comparison to their counterparts grown in YEPD. Our data indicate a potential role for Ape2 in the invasion of epithelial cells. APE2 expression is also strain-specific, and it is not related to isolation site or disease entity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25877008     DOI: 10.1007/s10096-015-2369-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Variations of enzymatic activity and biotypes of the yeast like fungi strains isolated from cancer patients.

Authors:  C Lukaszuk; E Krajewska-Kułak; W Niczyporuk; E Theodosopoulou; A Hatzopulu; M Krawczuk-Rybak; M Wojtukiewicz
Journal:  Rocz Akad Med Bialymst       Date:  2005

3.  Secreted proteinases and Candida albicans virulence.

Authors:  Frank C Odds
Journal:  Microbiology       Date:  2008-11       Impact factor: 2.777

4.  Ultrastructure of Candida albicans pleomorphic forms: phase-contrast microscopy, scanning and transmission electron microscopy.

Authors:  Monika Staniszewska; Małgorzata Bondaryk; Katarzyna Siennicka; Wiesław Kurzatkowski
Journal:  Pol J Microbiol       Date:  2012

5.  A recently evolved transcriptional network controls biofilm development in Candida albicans.

Authors:  Clarissa J Nobile; Emily P Fox; Jeniel E Nett; Trevor R Sorrells; Quinn M Mitrovich; Aaron D Hernday; Brian B Tuch; David R Andes; Alexander D Johnson
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

6.  New synthetic sulfone derivatives inhibit growth, adhesion and the leucine arylamidase APE2 gene expression of Candida albicans in vitro.

Authors:  Monika Staniszewska; Małgorzata Bondaryk; Zbigniew Ochal
Journal:  Bioorg Med Chem       Date:  2014-12-04       Impact factor: 3.641

7.  Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus.

Authors:  C S P Tsang; F C S Chu; W K Leung; L J Jin; L P Samaranayake; S C Siu
Journal:  J Med Microbiol       Date:  2007-10       Impact factor: 2.472

Review 8.  Onychomycosis--epidemiology, diagnosis and management.

Authors:  R Kaur; B Kashyap; P Bhalla
Journal:  Indian J Med Microbiol       Date:  2008 Apr-Jun       Impact factor: 0.985

9.  Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods.

Authors:  M A Pfaller; M Bale; B Buschelman; M Lancaster; A Espinel-Ingroff; J H Rex; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

10.  The in vitro effects of new D186 dendrimer on virulence factors of Candida albicans.

Authors:  Monika Staniszewska; Małgorzata Bondaryk; Paulina Zielińska; Zofia Urbańczyk-Lipkowska
Journal:  J Antibiot (Tokyo)       Date:  2014-04-02       Impact factor: 2.649

View more
  2 in total

1.  The Synergistic Effect of Azoles and Fluoxetine against Resistant Candida albicans Strains Is Attributed to Attenuating Fungal Virulence.

Authors:  Wenrui Gu; Dongmei Guo; Liuping Zhang; Dongmei Xu; Shujuan Sun
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 2.  Molecular and Physiological Study of Candida albicans by Quantitative Proteome Analysis.

Authors:  Seiji Shibasaki; Miki Karasaki; Wataru Aoki; Mitsuyoshi Ueda
Journal:  Proteomes       Date:  2018-09-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.